87 results on '"Lindquist, Lars"'
Search Results
2. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial
3. Recommendations to Improve Tick-Borne Encephalitis Surveillance and Vaccine Uptake in Europe
4. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial
5. Tick-borne encephalitis
6. Potential Virus Involvement in Alzheimer’s Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination
7. Whole genome sequencing of recurrent tuberculosis in Stockholm County 1996–2016
8. Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials
9. Alzheimer’s Disease Patients Receiving Antiviral Therapy: Case Reports
10. Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine
11. Impact of Improved Chromatographic Media on Productivity and Process Design in Downstream Processing
12. Tick-borne Encephalitis Vaccine Failures: A 10-year Retrospective Study Supporting the Rationale for Adding an Extra Priming Dose in Individuals Starting at Age 50 Years
13. Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection
14. Breadth and Dynamics of HLA-A2– and HLA-B7–Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection
15. Recent and historical trends in the epidemiology of Japanese encephalitis and its implication for risk assessment in travellers
16. Letter to the editor concerning comments by Hamer and Chen on Japanese encephalitis: vaccine options and timing of pre-travel vaccination
17. The burden of chickenpox disease in Sweden
18. NK Cell Responses to Human Tick-Borne Encephalitis Virus Infection
19. Phylogenetic Analysis of Ethiopian HIV-1 Subtype C Near Full-Length Genomes Reveals High Intrasubtype Diversity and a Strong Geographical Cluster
20. Burden of herpes zoster and post-herpetic neuralgia in Sweden
21. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial
22. Reply to Brouwer and van de Beek
23. Specificity and Dynamics of Effector and Memory CD8 T Cell Responses in Human Tick-Borne Encephalitis Virus Infection
24. Minority Drug-Resistant HIV-1 Variants in Treatment Naïve East-African and Caucasian Patients Detected by Allele-Specific Real-Time PCR
25. Polymorphisms in Chemokine Receptor 5 and Toll-Like Receptor 3 Genes Are Risk Factors for Clinical Tick-Borne Encephalitis in the Lithuanian Population
26. Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients
27. Neuro-Intensive Treatment Targeting Intracranial Hypertension Improves Outcome in Severe Bacterial Meningitis: An Intervention-Control Study
28. Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden
29. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study
30. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts
31. Early lumbar puncture in adult bacterial meningitis—rationale for revised guidelines
32. Acute Viral Infections of the Central Nervous System in Immunocompetent Adults: Diagnosis and Management
33. Optic nerve involvement in Lyme disease
34. Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
35. Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania
36. One-year Follow-up of Tick-borne Central Nervous System Infections in Childhood
37. Risk Factors for Mortality among HIV-Positive Patients with and without Active Tuberculosis in Dar Es Salaam, Tanzania
38. Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients
39. Pediatric tick-borne infections of the central nervous system in an endemic region of Sweden: a prospective evaluation of clinical manifestations
40. TICK-BORNE ENCEPHALITIS IN CHILDHOOD
41. A Functional Toll-Like Receptor 3 Gene (TLR3) May Be a Risk Factor for Tick-borne Encephalitis Virus (TBEV) Infection
42. Tick-borne encephalitis is associated with low levels of interleukin-10 in cerebrospinal fluid
43. Vaccination of children - summary and conclusions from a systematic reviewThe full review can be found in Acta Paediatrica 2010; 99: s461
44. Vaccine failures after active immunisation against tick-borne encephalitis
45. Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk
46. Tick-borne encephalitis
47. Tick-borne encephalitis (TBE) in childhood
48. Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients
49. A Deletion in the Chemokine Receptor 5(CCR5)Gene Is Associated with Tickborne Encephalitis
50. Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.